ADPT
Adaptive Biotechnologies Corp
27.90$
-0.6%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | -8.2% | +174.2% | +22.4% | -17.3% | -7.2% | -22.8% | -18.4% | -4.9% | |
| – | -12.0% | +239.0% | +18.6% | -44.6% | +39.6% | -27.0% | -30.8% | +5.8% | |
| – | -35.5% | +75.5% | +27.8% | +12.7% | -35.3% | -27.7% | -26.3% | +47.1% | |
| – | -14.1% | +249.6% | +19.3% | -48.7% | +41.1% | -30.5% | -35.8% | +2.1% | |
| – | -13.9% | +163.7% | -20.7% | +73.3% | +130.1% | -5.2% | +9.9% | +20.7% | |
| – | +63.6% | +15.7% | +55.1% | +37.0% | -25.0% | 0.0% | -41.6% | +16.4% | |
| – | +37.1% | +24.2% | +67.1% | +114.8% | -2.1% | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -11.1% | -12.5% | -14.3% | -16.6% | -19.9% | -24.9% | -33.2% | -49.6% | |
| – | +0.6% | -42.2% | +9.3% | -14.4% | +23.0% | -10.1% | -4.5% | -14.6% | |
| – | +8.6% | +243.5% | +34.3% | +8.2% | -3.5% | -19.8% | +11.4% | -8.3% | |
| – | – | – | – | +43.2% | +82.6% | +1.7% | +9.1% | +32.5% | |
| – | -8.7% | +148.4% | -27.3% | +2.2% | +144.5% | -4.5% | -5.9% | -11.0% | |
| – | -1.8% | – | – | – | – | – | – | – | |
| – | – | – | +30.2% | -18.7% | -23.2% | -33.6% | -34.3% | +7.9% | |
| – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +17.9% | +5.5% | +7.0% | +1.5% | +1.3% | +1.9% | +3.1% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.